azoxymethane has been researched along with phenylethyl 3-methylcaffeate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, S; Desai, D; Rao, CV; Reddy, BS; Rivenson, A; Simi, B | 1 |
| Kelloff, GJ; Rao, CV; Reddy, BS; Samaha, HS; Steele, V | 1 |
2 other study(ies) available for azoxymethane and phenylethyl 3-methylcaffeate
| Article | Year |
|---|---|
Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Body Weight; Caffeic Acids; Colon; Colonic Neoplasms; Evaluation Studies as Topic; Intestinal Mucosa; Lipoxygenase; Male; Phosphatidylinositol Diacylglycerol-Lyase; Phosphoinositide Phospholipase C; Phospholipases A; Phospholipases A2; Phosphoric Diester Hydrolases; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344 | 1995 |
Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Azoxymethane; Biomarkers, Tumor; Caffeic Acids; Carcinogens; Colonic Neoplasms; Curcumin; Isothiocyanates; Male; Rats; Rats, Inbred F344; Sulindac | 1997 |